Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA approves Janumet XR for type 2 diabetes

Feb. 3, 2012

Reviva Pharmaceuticals synthesizes new monoamine transporter inhibitors

Feb. 3, 2012

FDA advisory committee sets review date for lorcaserin NDA resubmission

Feb. 2, 2012

Mesoblast receives FDA clearance to conduct stem cell therapy study in diabetes

Feb. 1, 2012

Jentadueto approved in U.S.

Jan. 31, 2012

Roche presents novel AMPK activators

Jan. 31, 2012

European Commission requests further information in Glybera review

Jan. 30, 2012

FDA approves first-ever once-weekly treatment for type 2 diabetes

Jan. 30, 2012

Swissmedic grants marketing authorization for transdermal estradiol spray

Jan. 30, 2012

Histone deacetylase inhibitors may have potential in treating Gaucher's disease

Jan. 30, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...